MAPT and Alzheimer disease: Historically, CSF has served as the gold standard biological fluid for detecting neuropathologic biomarkers due to its proximity to brain tissue, with AD biomarkers such as decreased Aβ42 and increased total Tau (t-Tau) and phosphorylated Tau (p-Tau) [8,9].